Impacts of microbiome metabolites on immune regulation and autoimmunity

Immunology

Volumn 154, Issue 2, 2018, Pages 230-238

  Haase, Stefanie ^a   Haghikia, Aiden ^b   Wilck, Nicola ^c   Müller, Dominik N ^c,d,e   Linker, Ralf A ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^e BERLIN INSTITUTE OF HEALTH   (Germany)

Author keywords

experimental autoimmune encephalomyelitis; microbiome gut brain axis; multiple sclerosis; short chain fatty acids; T cells; tryptophan metabolites

Indexed keywords

PROBIOTIC AGENT; TRYPTOPHAN; VOLATILE FATTY ACID;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HOST; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; INTESTINE FLORA; METABOLITE; MICROBIOME; MICROFLORA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRYPTOPHAN METABOLISM; ANIMAL; DISEASE PREDISPOSITION; ENERGY METABOLISM; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; NEUROLOGIC DISEASE; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; DISEASE SUSCEPTIBILITY; ENERGY METABOLISM; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOMODULATION; MICROBIOTA; NEUROIMMUNOMODULATION; PROBIOTICS; TRYPTOPHAN;

EID: 85046106304     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12933     Document Type: Review

References (116)

1. Sedaghat F, Jessri M, Behrooz M, Mirghotbi M, Rashidkhani B. Mediterranean diet adherence and risk of multiple sclerosis: a case-control study. Asia Pac J Clin Nutr 2016; 25:377–84.
2. Hoare S, Lithander F, van der Mei I, Ponsonby A-L, Lucas R, Group for the AI. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the Ausimmune Study. Mult Scler J 2016; 22:884–92.
3. Riccio P, Rossano R, Larocca M, Trotta V, Mennella I, Vitaglione P et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med 2016; 241:620–35.
4. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496:518–22.
5. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496:513–7.
6. Jörg S, Kissel J, Manzel A, Kleinewietfeld M, Haghikia A, Gold R et al. High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells. Exp Neurol 2016; 279:212–22.
7. Farez MF, Fiol MP, Gaitán MI, Quintana FJ, Correale J. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015; 86:26–31.
8. Swank RL, Lerstad O, Strøm A, Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med 1952; 246:722–8.
9. Agranoff BW, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet Lond Engl 1974; 2:1061–6.
10. Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sørensen TIA et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler Houndmills Basingstoke Engl 2013; 19:1323–9.
11. Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 2015; 43:817–29.
12. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504:446–50.
13. Zhu X, Han Y, Du J, Liu R, Jin K, Yi W. Microbiota-gut-brain axis and the central nervous system. Oncotarget 2017; 8:53 829–38.
14. Kivisäkk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA 2003; 100:8389–94.
15. Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013; 19:1584–96.
16. Holmøy T, Hestvik ALK. Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr Opin Infect Dis 2008; 21:271–8.
17. Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 2013; 19:309–19.
18. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KHG. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010; 162:1–11.
19. Compston A, Coles A. Multiple sclerosis. Lancet Lond Engl 2008; 372:1502–17.
20. Raivich G, Banati R. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 2004; 46:261–81.
21. Prodinger C, Bunse J, Krüger M, Schiefenhövel F, Brandt C, Laman JD et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol (Berl) 2011; 121:445–58.
22. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80:695–705.
23. Pette M, Fujita K, Kitze B, Whitaker JN, Albert E, Kappos L et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 1990; 40:1770–6.
24. Bielekova B, Sung M-H, Kadom N, Simon R, McFarland H, Martin R. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. J Immunol 2004; 172:3893–904.
25. Rohowsky-Kochan C, Molinaro D, Cook SD. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis. Mult Scler J 2000; 6:69–77.
26. Wekerle H, Flügel A, Fugger L, Schett G, Serreze D. Autoimmunity's next top models. Nat Med 2012; 18:66–70.
27. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002; 415:536–41.
28. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421:744–8.
29. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198:1951–7.
30. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233–40.
31. Jäger A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17 and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009; 183:7169–77.
32. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177:566–73.
33. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 2009; 119:61–9.
34. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27:485–517.
35. Gálvez J. Role of Th17 cells in the pathogenesis of human IBD. ISRN Inflamm 2014; 2014:928 461.
36. Azizi G, Jadidi-Niaragh F, Mirshafiey A. Th17 cells in immunopathogenesis and treatment of rheumatoid arthritis. Int J Rheum Dis 2013; 16:243–53.
37. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009; 5:325–31.
38. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008; 172:146–55.
39. Kleinewietfeld M, Hafler DA. Regulatory T cells in autoimmune neuroinflammation. Immunol Rev 2014; 259:231–44.
40. Kleinewietfeld M, Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol 2013; 25:305–12.
41. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez-Llordella M, Ashby M et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10:1000–7.
42. Duarte JH, Zelenay S, Bergman M-L, Martins AC, Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 2009; 39:948–55.
43. Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004; 5:1149–56.
44. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007; 178:6725–9.
45. Koenen HJPM, Smeets RL, Vink PM, van Rijssen E, Boots AMH, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112:2340–52.
46. Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008; 38:3274–81.
47. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29:44–56.
48. Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens J-L et al. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008; 123:79–89.
49. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199:971–9.
50. Frisullo G, Nociti V, Iorio R, Patanella AK, Caggiula M, Marti A et al. Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients. Immunology 2009; 127:418–28.
51. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485–98.
52. H17 cell differentiation. Nature 2008; 455:808.
53. Hall J, Bouladoux N, Sun CM, Wohlfert E, Blank R, Zhu Q et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008; 29:637–49.
54. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016; 14:e1002533.
55. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222–7.
56. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature 2010; 464:59–65.
57. Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, Martens EC et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012; 336:1325–9.
58. Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol 2011; 2:94.
59. Forsythe P, Bienenstock J, Kunze WA. Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol 2014; 817:115–33.
60. Zhang H, Sparks JB, Karyala SV, Settlage R, Luo XM. Host adaptive immunity alters gut microbiota. ISME J 2015; 9:770–81.
61. Bengmark S. Gut microbiota, immune development and function. Pharmacol Res 2013; 69:87–113.
62. Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 2016; 28:12 015.
63. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One 2015; 10:e0137429.
64. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538–41.
65. Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J Exp Med 2009; 206:1303–16.
66. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009; 183:6041–50.
67. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16:228–31.
68. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 2011; 331:337–41.
69. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011; 108(Suppl 1):4578–85.
70. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003; 62:67–72.
71. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28:1221–7.
72. Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y et al. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res NYN 2008; 28:321–8.
73. Vinolo MAR, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 2011; 22:849–55.
74. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014; 111:2247–52.
75. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20:159–66.
76. Singh N, Thangaraju M, Prasad PD, Martin PM, Lambert NA, Boettger T et al. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J Biol Chem 2010; 285:27 601–8.
77. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J et al. Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 2015; 8:80–93.
78. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504:451–5.
79. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007; 13:1299–307.
80. Schilderink R, Verseijden C, de Jonge WJ. Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol 2013; 4:226. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730085/ (cited 2 February 2018).
81. Wu J, Zhou Z, Hu Y, Dong S. Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J Genet Genomics Yi Chuan Xue Bao 2012; 39:375–84.
82. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569–73.
83. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40:128–39.
84. Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, Lan L et al. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res 2014; 74:1166–78.
85. Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18:965–77.
86. Kocur M, Schneider R, Pulm A-K, Bauer J, Kropp S, Gliem M et al. IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathol Commun 2015; 3:20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383054/ (cited 5 February 2018).
87. Reemst K, Noctor SC, Lucassen PJ, Hol EM. The indispensable roles of microglia and astrocytes during brain development. Front Hum Neurosci 2016; 10:566. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099170/ (cited 5 February 2018).
88. Schilderink R, Verseijden C, Seppen J, Muncan V, van den Brink GR, Lambers TT et al. The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC. Am J Physiol Gastrointest Liver Physiol 2016; 310:G1138–46.
89. Hill JA, Hall JA, Sun C-M, Cai Q, Ghyselinck N, Chambon P et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 2008; 29:758–70.
90. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256–60.
91. Froushani SMA, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest 2014; 43:54–68.
92. Abdolahi M, Yavari P, Honarvar NM, Bitarafan S, Mahmoudi M, Saboor-Yaraghi AA. Molecular mechanisms of the action of vitamin A in Th17/Treg axis in multiple sclerosis. J Mol Neurosci MN 2015; 57:605–13.
93. Kim CH, Park J, Kim M. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw 2014; 14:277–88.
94. Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3:e1700492.
95. Salehipour Z, Haghmorad D, Sankian M, Rastin M, Nosratabadi R, Soltan Dallal MM et al. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomed Pharmacother 2017; 1:1535–48.
96. Mangalam A, Shahi SK, Luckey D, Karau M, Marietta E, Luo N et al. Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Rep 2017; 20:1269–77.
97. Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010; 5:e9009.
98. Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P et al. Investigation of probiotics in multiple sclerosis. Mult Scler J 2018; 24:58–63.
99. H17 axis and disease. Nature 2017; 551:585–89.
100. Hernandez AL, Kitz A, Wu C, Lowther DE, Rodriguez DM, Vudattu N et al. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest 2015; 125:4212–22.
101. Binger KJ, Gebhardt M, Heinig M, Rintisch C, Schroeder A, Neuhofer W et al. High salt reduces the activation of IL-4- and IL-13-stimulated macrophages. J Clin Invest 2015; 125:4223–38.
102. Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer 2013; 13:827–41.
103. H17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453:106–9.
104. Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2012; 109:11 270–5.
105. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453:65–71.
106. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013; 39:372–85.
107. Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22:586–97.
108. Amirkhani A, Rajda C, Arvidsson B, Bencsik K, Boda K, Seres E et al. Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients. Eur J Neurol 2005; 12:625–31.
109. Kim S, Yang JY, Lee K, Oh KH, Gi M, Kim JM et al. Bacillus subtilis-specific poly-gamma-glutamic acid regulates development pathways of naive CD4(+) T cells through antigen-presenting cell-dependent and -independent mechanisms. Int Immunol 2009; 21:977–90.
110. Lee K, Hwang S, Paik DJ, Kim WK, Kim JM, Youn J. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis. Clin Exp Immunol 2012; 170:66–76.
111. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107:12 204–9.
112. Erny D, Hrabě de Angelis AL, Prinz M. Communicating systems in the body: how microbiota and microglia cooperate. Immunology 2017; 150:7–15.
113. Visser L, deJan Heer H, Boven LA, van Riel D, van Meurs M, Melief M-J et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 2005;174:808–16.
114. Visser L, Melief M-J, van Riel D, van Meurs M, Sick EA, Inamura S et al. Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol 2006; 169:1671–85.
115. Schrijver IA, van Meurs M, Melief MJ, Wim Ang C, Buljevac D, Ravid R et al. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain J Neurol 2001; 124:1544–54.
116. Branton WG, Lu JQ, Surette MG, Holt RA, Lind J, Laman JD, Power C. Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep 2016; 6:37344.